十全大补汤配方颗粒对骨髓抑制小鼠造血调控的实验研究
|
摘要
目的：骨髓抑制是肿瘤放、化疗的主要毒副作用,表现为外周血单系或全系血细胞的减少。临床上,中医对放、化疗所致骨髓抑制的基本治疗原则是以“扶正”为主。本课题拟研究十全大补汤配方颗粒对骨髓抑制小鼠造血功能的调控作用及其可能机制。
方法：本研究从造血效应、造血干／祖细胞增殖力、细胞周期、细胞周期素、细胞周期依赖性蛋白激酶、骨髓基质细胞、细胞外基质、造血生长因子等方面着手,应用细胞培养术、流式细胞术、免疫组织化学术、蛋白免疫印迹法、酶联免疫吸附法以及半定量—聚合酶链反应等技术,较系统地研究十全大补汤配方颗粒对骨髓抑制小鼠造血功能的调控作用及相关机制。
结果：
1在一定剂量范围内,十全大补汤配方颗粒可明显提高骨髓抑制小鼠外周血WBC、RBC、Hb、PLT数量,增加骨髓有核细胞数,促进骨髓显微组织结构损伤的修复,增加骨髓造血面积；
2十全大补汤配方颗粒可有效提高骨髓抑制小鼠粒系、红系和巨核系体外造血祖细胞培养集落产率；
3从造血效应方面来考察,十全大补汤配方颗粒与标准汤剂对骨髓抑制小鼠造血功能的恢复均有促进作用,两者比较无明显统计学差异；
4十全大补汤配方颗粒可使骨髓抑制小鼠G0／G1期细胞减少,S期和G2／M期细胞增多,增殖指数增加,同时降低骨髓细胞凋亡率。
5十全大补汤配方颗粒可促进细胞周期调控蛋白细胞周期素CyclinD1、CyclinEmRNA和细胞周期依赖性蛋白激酶CDK2、CDK4mRNA基因的表达,进而调控细胞周期时程；
6十全大补汤配方颗粒可上调肾脏EPOmRNA、脾脏TPOmRNA、骨髓细胞EPO和GM-CSFmRNA的表达,增加血清EPO、TPO和GM-CSF的含量,促进骨髓三系血细胞造血；
7十全大补汤配方颗粒可促进骨髓基质中FN、LN蛋白表达,抑制MMP-2、MMP-7、MMP-9蛋白表达,增强骨髓基质细胞粘附力；
结论：在一定剂量范围内,十全大补汤配方颗粒能有效促进骨髓抑制小鼠造血功能的恢复。其机制可能是：通过解除骨髓细胞的细胞周期阻滞,促进骨髓细胞增殖；改善骨髓造血微环境,促进造血干／祖细胞的黏附和归巢；促进造血生长因子的表达进而改善骨髓三系血细胞的造血功能。从总体造血效应方面考察,十全大补汤配方颗粒与标准汤剂在改善骨髓抑制小鼠造血功能方面无明显差异。
Objective:Myelosuppression is followed, when the cancer patients undergo radiotherapy and chemotherapy.The basic principle of treatment for myelosuppression is based on "Fuzheng" mainly. In this study, our aim was to explore the effect of Shiquandabu Tang Granules on hematopoietic regulation and its mechanisms, and provide experiment data for the improvement form of medication.
Methods:In the present study, the model of myelosuppressed mice was prepared by 60Coγirradiation, cyclophosphamide injection and chloramphenicol injection. Hematopoietic progenitor cells culture, flow cytometry, immunohistochemistry(IHC), western blot method(WB), Enzyme-linked immuno-sorbent assay (ELISA), as well as semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) technologies are used to study the hematopoietic effects, proliferation of bone marrow nuclear cells, and cell cycle, cyclin, cyclin-dependent kinase, as well as bone marrow stromal cells, extracellular matrix of bone marrow hematopoietic microenvironment and other aspects. We explored systematically and deeply the effect of Shiquandabu Tang Granules on hematopoietic system and its mechanisms.
Results:
1 Within a certain dose range, Shiquandabu Tang Granules could significantly increase the number of white blood cell(WBC), red blood cell(RBC), hemoglobin(Hb) and platelet (PLT); increase the number of bone marrow nucleated cells; increase hematopoietic tissue area in bone marrow;
2 Shiquandabu Tang Granules could effectively improve the colony forming-unit-erythroid(CFU-E),burst colony forming-unit-erythroid (BFU-E), colony forming-unit-granulocytemacrophage(CFU-GM), colony forming-unit-megakaryocyte(CFU-Meg);
3 There has no significant difference between the Shiquandabu Tang Granules and the traditional decoction in improving the bone marrow hematopoietic function of myelosuppressed mice;
4 Shiquandabu Tang Granules could promote bone marrow cells into the cell cycle, promote the G0/G1 phase cells into S phase, S phase cells into G2/M phase transformation, thereby promoting the proliferation of bone marrow cells.
5 Shiquandabu Tang Granules could promote gene expression of cell cycle regulatory protein (CyclinD1, CyclinE) and cyclin-dependent kinase (CDK2, CDK4);
6 Shiquandabu Tang Granules could promote gene expression of EPOmRAN in Kidney and BMC, TPOmRNA in spleen, GM-CSFmRNA in BMC, increase the level of serum EPO, TPO and GM-CSF;.
7 Shiquandabu Tang Granules could promote early hematopoietic stem/progenitor cells adhesion and homing by increasing the adhesion of bone marrow stromal cells, promoting the expression of FN, LN, and inhibiting the expression of MMP-2, MMP-7, MMP-9 in extracellular matrix of bone marrow.
Conclusion:Within a certain dose range, Shiquandabu Tang Granules could promote effectively the recovery of impaired hematopoietic function in myelosuppressed mice. The main channels may be regulating cell cycle of BMC, improving the bone marrow micro-environment, promoting the gene expression of hematopoietic growth factors. There has no significant difference between the Shiquandabu Tang Granules and the traditional decoction in improving the bone marrow hematopoietic function of myelosuppressed mice.
方法：本研究从造血效应、造血干／祖细胞增殖力、细胞周期、细胞周期素、细胞周期依赖性蛋白激酶、骨髓基质细胞、细胞外基质、造血生长因子等方面着手,应用细胞培养术、流式细胞术、免疫组织化学术、蛋白免疫印迹法、酶联免疫吸附法以及半定量—聚合酶链反应等技术,较系统地研究十全大补汤配方颗粒对骨髓抑制小鼠造血功能的调控作用及相关机制。
结果：
1在一定剂量范围内,十全大补汤配方颗粒可明显提高骨髓抑制小鼠外周血WBC、RBC、Hb、PLT数量,增加骨髓有核细胞数,促进骨髓显微组织结构损伤的修复,增加骨髓造血面积；
2十全大补汤配方颗粒可有效提高骨髓抑制小鼠粒系、红系和巨核系体外造血祖细胞培养集落产率；
3从造血效应方面来考察,十全大补汤配方颗粒与标准汤剂对骨髓抑制小鼠造血功能的恢复均有促进作用,两者比较无明显统计学差异；
4十全大补汤配方颗粒可使骨髓抑制小鼠G0／G1期细胞减少,S期和G2／M期细胞增多,增殖指数增加,同时降低骨髓细胞凋亡率。
5十全大补汤配方颗粒可促进细胞周期调控蛋白细胞周期素CyclinD1、CyclinEmRNA和细胞周期依赖性蛋白激酶CDK2、CDK4mRNA基因的表达,进而调控细胞周期时程；
6十全大补汤配方颗粒可上调肾脏EPOmRNA、脾脏TPOmRNA、骨髓细胞EPO和GM-CSFmRNA的表达,增加血清EPO、TPO和GM-CSF的含量,促进骨髓三系血细胞造血；
7十全大补汤配方颗粒可促进骨髓基质中FN、LN蛋白表达,抑制MMP-2、MMP-7、MMP-9蛋白表达,增强骨髓基质细胞粘附力；
结论：在一定剂量范围内,十全大补汤配方颗粒能有效促进骨髓抑制小鼠造血功能的恢复。其机制可能是：通过解除骨髓细胞的细胞周期阻滞,促进骨髓细胞增殖；改善骨髓造血微环境,促进造血干／祖细胞的黏附和归巢；促进造血生长因子的表达进而改善骨髓三系血细胞的造血功能。从总体造血效应方面考察,十全大补汤配方颗粒与标准汤剂在改善骨髓抑制小鼠造血功能方面无明显差异。
Objective:Myelosuppression is followed, when the cancer patients undergo radiotherapy and chemotherapy.The basic principle of treatment for myelosuppression is based on "Fuzheng" mainly. In this study, our aim was to explore the effect of Shiquandabu Tang Granules on hematopoietic regulation and its mechanisms, and provide experiment data for the improvement form of medication.
Methods:In the present study, the model of myelosuppressed mice was prepared by 60Coγirradiation, cyclophosphamide injection and chloramphenicol injection. Hematopoietic progenitor cells culture, flow cytometry, immunohistochemistry(IHC), western blot method(WB), Enzyme-linked immuno-sorbent assay (ELISA), as well as semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) technologies are used to study the hematopoietic effects, proliferation of bone marrow nuclear cells, and cell cycle, cyclin, cyclin-dependent kinase, as well as bone marrow stromal cells, extracellular matrix of bone marrow hematopoietic microenvironment and other aspects. We explored systematically and deeply the effect of Shiquandabu Tang Granules on hematopoietic system and its mechanisms.
Results:
1 Within a certain dose range, Shiquandabu Tang Granules could significantly increase the number of white blood cell(WBC), red blood cell(RBC), hemoglobin(Hb) and platelet (PLT); increase the number of bone marrow nucleated cells; increase hematopoietic tissue area in bone marrow;
2 Shiquandabu Tang Granules could effectively improve the colony forming-unit-erythroid(CFU-E),burst colony forming-unit-erythroid (BFU-E), colony forming-unit-granulocytemacrophage(CFU-GM), colony forming-unit-megakaryocyte(CFU-Meg);
3 There has no significant difference between the Shiquandabu Tang Granules and the traditional decoction in improving the bone marrow hematopoietic function of myelosuppressed mice;
4 Shiquandabu Tang Granules could promote bone marrow cells into the cell cycle, promote the G0/G1 phase cells into S phase, S phase cells into G2/M phase transformation, thereby promoting the proliferation of bone marrow cells.
5 Shiquandabu Tang Granules could promote gene expression of cell cycle regulatory protein (CyclinD1, CyclinE) and cyclin-dependent kinase (CDK2, CDK4);
6 Shiquandabu Tang Granules could promote gene expression of EPOmRAN in Kidney and BMC, TPOmRNA in spleen, GM-CSFmRNA in BMC, increase the level of serum EPO, TPO and GM-CSF;.
7 Shiquandabu Tang Granules could promote early hematopoietic stem/progenitor cells adhesion and homing by increasing the adhesion of bone marrow stromal cells, promoting the expression of FN, LN, and inhibiting the expression of MMP-2, MMP-7, MMP-9 in extracellular matrix of bone marrow.
Conclusion:Within a certain dose range, Shiquandabu Tang Granules could promote effectively the recovery of impaired hematopoietic function in myelosuppressed mice. The main channels may be regulating cell cycle of BMC, improving the bone marrow micro-environment, promoting the gene expression of hematopoietic growth factors. There has no significant difference between the Shiquandabu Tang Granules and the traditional decoction in improving the bone marrow hematopoietic function of myelosuppressed mice.
引文
[1]陈奇.中药药理研究方法学[M].北京：人民卫生出版社,1996：1103.
[2]Dainiak N. Hematologic consequences of exposure to ionizing radiation [J]. Exp Hematol,2002,30(6):513-528.
[3]Kluck RM, Bossy-Wetzel E, Green DR, etal. The release of cytochromec from Mitochondria, a primary site for Bcl-2 regulation of apoptosis [J]. Science,1997,275:1132-1136.
[4]储真真,陈信义,李宏.对化疗后骨髓抑制的中医临床理论探讨与防治对策[J].中华中医药杂志,2005,20(11)：676-678.
[5]曹志然,周文英,陈淑兰等.十全大补汤对小鼠溶血素水平及脾指数的影响[J].中国现代医学杂志,2000,10(12)：46-47.
[6]张涛,柳朝阳,王建杰等,十全大补汤对60Co γ照射小鼠免疫功能的影响[J].黑龙江医药科学,2003,26(5)：60.
[7]陈玉春,高依卿,王碧英.十全大补汤免疫调节作用的实验研究[J].中国中医药科技,2005,12(3)：158-159.
[8]包素珍,郑小伟,孙在典等.十全大补汤对H22肝癌小鼠免疫功能的影响[J].中国中医药信息杂志,2006,13(6)：33-34.
[9]孙在典,郑小伟,包素珍,等.十全大补汤_CTX抑瘤作用及对生活质量影响的比较研究[J].中华中医药学刊,2007,25(11)：2408-2409.
[10]包素珍,郑小伟,孙在典,等.十全大补汤诱导肝癌H_22_小鼠肿瘤细胞凋亡实验研究[J].中国中医急症,2006,15(5)：518,520.
[11]包素珍,郑小伟,孙在典,等.十全大补汤抗小鼠Lewis肺癌转移的实验研究,中医药学刊[J],2005,23(6)：1018-1019.
[12]韩艳梅,曹志然,王晓辉,等.十全大补汤对移植乳腺癌小鼠化疗的减毒增效作用[J],军医进修学院学报,2007,28(5)：358-359.
[13]罗海鸥,张春,刘绍唐,等.十全大补汤对抗5—Fu化疗骨髓抑制的实验研究[J].中医研究,2003,16(1)：18-21.
[14]李澎涛,乔延江,王永炎,等.对中药复方研究的思考[J].北京中医药大学学报,1999,22(5)：15-17.
[15]黄泰康,王米渠.中医分子生物学[M].北京：中国医药科技出版社,2003,166—279.
[16]王保秀,朱伟.中药配方颗粒的优势与发展前景[J].中国中医药信息杂志,2005,12(2)：6-9.
[17]陆泽检.中药饮片浓缩颗粒值得尝试[M].中药浓缩颗粒的临床应用与研究,北京：人民卫生出版社,1998：11-14.
[18]姚莉.辐射损伤与细胞周期[J].国外医学.放射医学核医学分册,2004,28(1)：33—36.
[19]吴家睿.细胞周期检查点的分子机制[J].生物工程进展,1999,19(4)：7-10.
[20]Zhu XL, Zhu BD. Effect of AMI on roliferative cycle phase of bone marrow cells in mice[J].J Chin Med Mater(中药材),2000,23(10):625-627.
[21]刘屏,王东晓,陈若芸,等.儿茶素对骨髓细胞周期及造血生长因子基因表达的作用[J].药学学报.2004,39(6)：424—428.
[22]Denenkamp, J. Cell kinetics and radiation biology[J]. Radiat Boil,1986; 49(8):357-362.
[23]皱仲敏,罗成基.细胞凋亡和细胞增殖抑制在神仙损伤造血功能中的作用[J].第三军医大学学报,1997,4(6)：136-137.
[24]Byron JW. Manipulation of the cell cycle of the hemopoietic stem cell[J] Exp Hemet,1975;3:44-53.
[25]Sherr CJ.Cancer cell cycles.Science,1996,274(5293):1672.
[26]Sherr CJ. The Pezcoller lecture:Cancer cell cycles revisited. Cancer Res,2001,60(14):3689.
[27]马淑梅,付士波,鞠桂芝.电离辐射对小鼠骨髓造血细胞周期进程的影响[J].辐射研究与辐射工艺学报,2000,18(2)：104-107.
[28]Murray AW, Marks D. Can sequencing shed light on cell cycling? [J]. Nature,2001,409(6822):844-846.
[29]王霞,李萍.细胞周期调控与肿瘤研究进展[J].中国医学检验杂志,2006,7(1)：59-61.
[30]朱江军,叶绍明.骨肉瘤G1细胞周期调控因子研究进展[J].国际骨科学杂
志,2006,27(6)：344-347.
[31]Reed SI.Control of the G1/S transition[J]. Cancer Surv,1997, 29(5):7-23.
[32]Ando K, Ajchenbaum-Cymbalista F, Griffin JD. Regulation of G1/S transition by cyclinsD2 and cyclinD3 in hematopoietic cells[J]. Proc Natl Acad Sci,1993,90(20):9571-9575.
[33]Ogawa M. Differentiation and proliferation of hematopoietic stem cell[J].Blood,1993;83:2844-2853.
[34]吴祖泽,贺福初,裴雪涛.造血调控[M].上海：上海医科大学出版社,2000：9.
[35]Jaclbson LO, Goldwasser E, Friend W, etal. Role of the kidey in erythropoiesis[J]. Nature,1957,179(2):633-634.
[36]Erslev AJ.Erythropoietin. Leuk Res.1990,14(8):683-688.
[37]Cardier JE, Erickson-Miller CL, Murphy MJ Jr. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Stem Cells.1997,15(4):286-290.
[38]Tsukada J, Misago M, Kikuchi M, et al. The effect of high doses of recombinant human erythropoietin on megakaryocytopoiesis and platelet production in splenectomizedmice. Br J Haematol.1990,76(2):260-268.
[39]Maxwelll PH, Ferguson DJ,Nicholls LG, etal, Ratcliffe PJ. Sites of erythropoietin production[J]. Kidney Int,1997,51 (2)393-401.
[40]Rich IN, Heit W, Kubane B. Extrarenal erythropoietin production by macrophages[J]. Blood.1982,60(4):1007-1018.
[41]Rich IN, Anselstetter V, Heit W, et al. Release of erythropoietin from macrophages by treatment with silica[J].J Supramol Struct Cell Biochem.1981,15(2):169-176.
[42]Rich IN, Kubanek B. Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica[J]. J Reticuloendothel Soc.1982,31(1):17-30.
[43]Schuster SJ, Badiavas EV, Coste-Giamo P, etal. Stimulation of erythropie tingene transcription during hypoxia and cobait exposure[J]. Blood,1998,73 (1):13-16.
[44]Rich IN, Kubanek B. Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica. J Reticuloendothel Soc.1982,31(1):17-30.
[45]Cong YW, Chen JP,Shao Y.Studies on the changes in growth responsiveness of Responsiveness of hematopoietic cells to hematopoietic growth factors after irrdiation[J]. Bull Acad Mil Med Sci(军事医学科学院院刊),1999,23 (2):119-122.
[46]刘屏,王东晓,陈若芸,等.儿茶素对骨髓细胞周期及造血生长因子基因表达的作用[J].药学学报(Acta Pharmaceutica Sinica),2004,39(6)：424-428.
[47]Vannucchi AM, Grossi A, Rafanelli D, et al. In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor[J]. Blood.1990,76(8):1473-80.
[48]孙艳辉,侯相麟,李兴玉.巴西蘑菇多糖对小鼠脑组织表达粒2巨噬细胞集落刺激因子的影响[J].中国临床药理学与治疗学,2004,9(7)：799-802.
[49]陈笛,王莎莉,王亚平,等.人参总皂甙诱导淋巴细胞表达GM-CSF的实验研究[J].免疫学杂志,2001,19(6)：411-414.
[50]陈笛,王莎莉,王亚平,等.人参总皂甙诱导人内皮细胞和单核细胞表达GMCSF的实验研究[J].中国中西医结合杂志,2003,23(11)：845-847.
[51]陈笛,王莎莉,王亚平,等。人参总皂甙诱导人骨髓基质细胞表达GM-CSF的实验研究[J].重庆医科大学学报,2003,28(4)：405-408.
[52]王志东.GM-CSF在辐射后的变化及其在辐射损伤治疗中的作用[J].国外医学,放射医学核医学分册,2003,27(1)：38-41.
[53]Liu FY, Wang JN, Yu SD, et al. Effect of panaxatriol on hematogenesis and granulocyte-macrophage colony stimulating factor in radiation injured mice[J]. Saudi Med J.2007,28(12):1791-1795.
[54]Miyazaki H, Yanagida M, etal. Purification of rat megakaryocyte colony-Forming cells using a monoclonal antibody against rat platelet glycoprotein Ⅱb/Ⅲa[J]. Exp, Hematol 1992,20:855-861.
[55]Wending F, Maraskovsky E, Debili N, etal. Ligand is a humeral regulator Of megakaryocytopoiesis[J]. Nature 1994,369:571-574.
[56]Koushansky K, Lok S, Holly RD, etal. Promotion of megalary ocyte progenitor expension and differentiation by the c-mpl ligand thrombopoietin[J].Nature,1994,369(6481):568.
[57]Kato T, Horie K, Hagiwara T, etal. GpⅡb/Ⅲa subpopulation of rat Megakaryocytic progenitor cells exhibits high responsiveness to human Thrombopoietin[J]. Exp Hematology,1996,24: 1209-1214.
[58]Drachman JG.. Role of thrombopoietin in hematopoietic stem cell and progenitor regulation. [J]. Curr Opin Hematol,2000,7(3):183.
[59]Fujiwara T, Harigae H, Kameoka J, et al. A case of familial thrombocytosis:possible role of altered thrombopoietin production[J]. Hematol,2004,76(4):395.
[60]陈笛,王莎莉,王亚平,等.人参总皂甙诱导人骨髓基质细胞表达GM-CSF的实验研究[J].重庆医科大学学报,2003,28(4)：405-408.
[61]Kato T, Oda A,Inagaki Y, etal.Thrombin cleaves recombinant human Thrombopoietin:one of the proteolytic events that generates forms Of thrombopoietin[J]. Proc Natl Acad Sci USA, 1997,74:4669-4674.
[62]Sungaran R, Markovic B, Chong BH. Localization and regulation of Thrombopoietin mRNA expression in human kidney, liver, bone
marrow, and Spleen using in situ hybridization[J]. Blood,1997,89:101-107.
[63]Ranita Sungaran, Orin T.Chisholm, etal. The role of platelet a-granular proteins in the regulation of thrombopoietin messenger RNA
Expression in human bone marrow stoma cells. Blood,2000,95(10):3094-3101.
[64]Fukushima N, Ohkawa H. Hmatopoietic stem cells and microenviroment: The proliferation and differentiation of stromal cells[J]. Crit Rev Oncol Hematol.1995,20:255-270.
[65]Yoder MC, Williams DA. Matrix molecule interactions with hematopoietic Stem cells[J].Exp Hematology,1995,23(9):961-976.
[66]Greenberger JS, Toxic effects on the hematopoietic micreenvironment [J].Exp Hematol,1991,19(4):1101-1109.
[67]Greenberger JS, Epperly MW, Jahroudi N, etal. Role of bone marrow stoma Cells in irradiation leukemogenesis. Acta Hematol [J],1996,96(1):1-15.
[68]Dainiak N. Hematologic consequences of exposure to ionizing radiation [J]. Exp Hematol,2002,30(6):513-528.
[69]Yang XB, Bhatnagar RS, Li S,etal. Biomimetic collagen scaffolds for Human bone cell growth and differentiation[J]. Tissue Eng,2004,10(7-8):1148-1159.
[72]李成章,任铁冠,樊明文.基质金属蛋白酶家族[J].口腔医学纵横杂志,1998,14(1)：50-53.
[73]Carlo Bastianutto, Asim Mian, Julie Symes, etal. Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow[J]. Cancer Res 2007,10112-10116.
[74]Anna Janowska-Wieczorek, Leah A, Marquez,etal. Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD341 Cells and Their Transmigration Through Reconstituted Basement Membrane[J]. Blood,93(10),1999,3379-3390.
[75]靳风艳,邱录贵,李桥川,等.基质金属蛋白酶9在粒细胞集落刺激因子诱导的造血干／祖细胞动员中的作用[J].2006,86(42)：2966-2970.
[76]Rafii S, Avecilla S, Shmelklv S, etal. Angiogenic factors reconstitute Hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann NY Acad Sci,2003,990:49.
[77]E. Camilla Forsberg, Susan S Prohaska, Sol Katzman, Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells. PLoS Genet.2005,1 (3):28.
[2]Dainiak N. Hematologic consequences of exposure to ionizing radiation [J]. Exp Hematol,2002,30(6):513-528.
[3]Kluck RM, Bossy-Wetzel E, Green DR, etal. The release of cytochromec from Mitochondria, a primary site for Bcl-2 regulation of apoptosis [J]. Science,1997,275:1132-1136.
[4]储真真,陈信义,李宏.对化疗后骨髓抑制的中医临床理论探讨与防治对策[J].中华中医药杂志,2005,20(11)：676-678.
[5]曹志然,周文英,陈淑兰等.十全大补汤对小鼠溶血素水平及脾指数的影响[J].中国现代医学杂志,2000,10(12)：46-47.
[6]张涛,柳朝阳,王建杰等,十全大补汤对60Co γ照射小鼠免疫功能的影响[J].黑龙江医药科学,2003,26(5)：60.
[7]陈玉春,高依卿,王碧英.十全大补汤免疫调节作用的实验研究[J].中国中医药科技,2005,12(3)：158-159.
[8]包素珍,郑小伟,孙在典等.十全大补汤对H22肝癌小鼠免疫功能的影响[J].中国中医药信息杂志,2006,13(6)：33-34.
[9]孙在典,郑小伟,包素珍,等.十全大补汤_CTX抑瘤作用及对生活质量影响的比较研究[J].中华中医药学刊,2007,25(11)：2408-2409.
[10]包素珍,郑小伟,孙在典,等.十全大补汤诱导肝癌H_22_小鼠肿瘤细胞凋亡实验研究[J].中国中医急症,2006,15(5)：518,520.
[11]包素珍,郑小伟,孙在典,等.十全大补汤抗小鼠Lewis肺癌转移的实验研究,中医药学刊[J],2005,23(6)：1018-1019.
[12]韩艳梅,曹志然,王晓辉,等.十全大补汤对移植乳腺癌小鼠化疗的减毒增效作用[J],军医进修学院学报,2007,28(5)：358-359.
[13]罗海鸥,张春,刘绍唐,等.十全大补汤对抗5—Fu化疗骨髓抑制的实验研究[J].中医研究,2003,16(1)：18-21.
[14]李澎涛,乔延江,王永炎,等.对中药复方研究的思考[J].北京中医药大学学报,1999,22(5)：15-17.
[15]黄泰康,王米渠.中医分子生物学[M].北京：中国医药科技出版社,2003,166—279.
[16]王保秀,朱伟.中药配方颗粒的优势与发展前景[J].中国中医药信息杂志,2005,12(2)：6-9.
[17]陆泽检.中药饮片浓缩颗粒值得尝试[M].中药浓缩颗粒的临床应用与研究,北京：人民卫生出版社,1998：11-14.
[18]姚莉.辐射损伤与细胞周期[J].国外医学.放射医学核医学分册,2004,28(1)：33—36.
[19]吴家睿.细胞周期检查点的分子机制[J].生物工程进展,1999,19(4)：7-10.
[20]Zhu XL, Zhu BD. Effect of AMI on roliferative cycle phase of bone marrow cells in mice[J].J Chin Med Mater(中药材),2000,23(10):625-627.
[21]刘屏,王东晓,陈若芸,等.儿茶素对骨髓细胞周期及造血生长因子基因表达的作用[J].药学学报.2004,39(6)：424—428.
[22]Denenkamp, J. Cell kinetics and radiation biology[J]. Radiat Boil,1986; 49(8):357-362.
[23]皱仲敏,罗成基.细胞凋亡和细胞增殖抑制在神仙损伤造血功能中的作用[J].第三军医大学学报,1997,4(6)：136-137.
[24]Byron JW. Manipulation of the cell cycle of the hemopoietic stem cell[J] Exp Hemet,1975;3:44-53.
[25]Sherr CJ.Cancer cell cycles.Science,1996,274(5293):1672.
[26]Sherr CJ. The Pezcoller lecture:Cancer cell cycles revisited. Cancer Res,2001,60(14):3689.
[27]马淑梅,付士波,鞠桂芝.电离辐射对小鼠骨髓造血细胞周期进程的影响[J].辐射研究与辐射工艺学报,2000,18(2)：104-107.
[28]Murray AW, Marks D. Can sequencing shed light on cell cycling? [J]. Nature,2001,409(6822):844-846.
[29]王霞,李萍.细胞周期调控与肿瘤研究进展[J].中国医学检验杂志,2006,7(1)：59-61.
[30]朱江军,叶绍明.骨肉瘤G1细胞周期调控因子研究进展[J].国际骨科学杂
志,2006,27(6)：344-347.
[31]Reed SI.Control of the G1/S transition[J]. Cancer Surv,1997, 29(5):7-23.
[32]Ando K, Ajchenbaum-Cymbalista F, Griffin JD. Regulation of G1/S transition by cyclinsD2 and cyclinD3 in hematopoietic cells[J]. Proc Natl Acad Sci,1993,90(20):9571-9575.
[33]Ogawa M. Differentiation and proliferation of hematopoietic stem cell[J].Blood,1993;83:2844-2853.
[34]吴祖泽,贺福初,裴雪涛.造血调控[M].上海：上海医科大学出版社,2000：9.
[35]Jaclbson LO, Goldwasser E, Friend W, etal. Role of the kidey in erythropoiesis[J]. Nature,1957,179(2):633-634.
[36]Erslev AJ.Erythropoietin. Leuk Res.1990,14(8):683-688.
[37]Cardier JE, Erickson-Miller CL, Murphy MJ Jr. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions. Stem Cells.1997,15(4):286-290.
[38]Tsukada J, Misago M, Kikuchi M, et al. The effect of high doses of recombinant human erythropoietin on megakaryocytopoiesis and platelet production in splenectomizedmice. Br J Haematol.1990,76(2):260-268.
[39]Maxwelll PH, Ferguson DJ,Nicholls LG, etal, Ratcliffe PJ. Sites of erythropoietin production[J]. Kidney Int,1997,51 (2)393-401.
[40]Rich IN, Heit W, Kubane B. Extrarenal erythropoietin production by macrophages[J]. Blood.1982,60(4):1007-1018.
[41]Rich IN, Anselstetter V, Heit W, et al. Release of erythropoietin from macrophages by treatment with silica[J].J Supramol Struct Cell Biochem.1981,15(2):169-176.
[42]Rich IN, Kubanek B. Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica[J]. J Reticuloendothel Soc.1982,31(1):17-30.
[43]Schuster SJ, Badiavas EV, Coste-Giamo P, etal. Stimulation of erythropie tingene transcription during hypoxia and cobait exposure[J]. Blood,1998,73 (1):13-16.
[44]Rich IN, Kubanek B. Release of erythropoietin from macrophages mediated by phagocytosis of crystalline silica. J Reticuloendothel Soc.1982,31(1):17-30.
[45]Cong YW, Chen JP,Shao Y.Studies on the changes in growth responsiveness of Responsiveness of hematopoietic cells to hematopoietic growth factors after irrdiation[J]. Bull Acad Mil Med Sci(军事医学科学院院刊),1999,23 (2):119-122.
[46]刘屏,王东晓,陈若芸,等.儿茶素对骨髓细胞周期及造血生长因子基因表达的作用[J].药学学报(Acta Pharmaceutica Sinica),2004,39(6)：424-428.
[47]Vannucchi AM, Grossi A, Rafanelli D, et al. In vivo stimulation of megakaryocytopoiesis by recombinant murine granulocyte-macrophage colony-stimulating factor[J]. Blood.1990,76(8):1473-80.
[48]孙艳辉,侯相麟,李兴玉.巴西蘑菇多糖对小鼠脑组织表达粒2巨噬细胞集落刺激因子的影响[J].中国临床药理学与治疗学,2004,9(7)：799-802.
[49]陈笛,王莎莉,王亚平,等.人参总皂甙诱导淋巴细胞表达GM-CSF的实验研究[J].免疫学杂志,2001,19(6)：411-414.
[50]陈笛,王莎莉,王亚平,等.人参总皂甙诱导人内皮细胞和单核细胞表达GMCSF的实验研究[J].中国中西医结合杂志,2003,23(11)：845-847.
[51]陈笛,王莎莉,王亚平,等。人参总皂甙诱导人骨髓基质细胞表达GM-CSF的实验研究[J].重庆医科大学学报,2003,28(4)：405-408.
[52]王志东.GM-CSF在辐射后的变化及其在辐射损伤治疗中的作用[J].国外医学,放射医学核医学分册,2003,27(1)：38-41.
[53]Liu FY, Wang JN, Yu SD, et al. Effect of panaxatriol on hematogenesis and granulocyte-macrophage colony stimulating factor in radiation injured mice[J]. Saudi Med J.2007,28(12):1791-1795.
[54]Miyazaki H, Yanagida M, etal. Purification of rat megakaryocyte colony-Forming cells using a monoclonal antibody against rat platelet glycoprotein Ⅱb/Ⅲa[J]. Exp, Hematol 1992,20:855-861.
[55]Wending F, Maraskovsky E, Debili N, etal. Ligand is a humeral regulator Of megakaryocytopoiesis[J]. Nature 1994,369:571-574.
[56]Koushansky K, Lok S, Holly RD, etal. Promotion of megalary ocyte progenitor expension and differentiation by the c-mpl ligand thrombopoietin[J].Nature,1994,369(6481):568.
[57]Kato T, Horie K, Hagiwara T, etal. GpⅡb/Ⅲa subpopulation of rat Megakaryocytic progenitor cells exhibits high responsiveness to human Thrombopoietin[J]. Exp Hematology,1996,24: 1209-1214.
[58]Drachman JG.. Role of thrombopoietin in hematopoietic stem cell and progenitor regulation. [J]. Curr Opin Hematol,2000,7(3):183.
[59]Fujiwara T, Harigae H, Kameoka J, et al. A case of familial thrombocytosis:possible role of altered thrombopoietin production[J]. Hematol,2004,76(4):395.
[60]陈笛,王莎莉,王亚平,等.人参总皂甙诱导人骨髓基质细胞表达GM-CSF的实验研究[J].重庆医科大学学报,2003,28(4)：405-408.
[61]Kato T, Oda A,Inagaki Y, etal.Thrombin cleaves recombinant human Thrombopoietin:one of the proteolytic events that generates forms Of thrombopoietin[J]. Proc Natl Acad Sci USA, 1997,74:4669-4674.
[62]Sungaran R, Markovic B, Chong BH. Localization and regulation of Thrombopoietin mRNA expression in human kidney, liver, bone
marrow, and Spleen using in situ hybridization[J]. Blood,1997,89:101-107.
[63]Ranita Sungaran, Orin T.Chisholm, etal. The role of platelet a-granular proteins in the regulation of thrombopoietin messenger RNA
Expression in human bone marrow stoma cells. Blood,2000,95(10):3094-3101.
[64]Fukushima N, Ohkawa H. Hmatopoietic stem cells and microenviroment: The proliferation and differentiation of stromal cells[J]. Crit Rev Oncol Hematol.1995,20:255-270.
[65]Yoder MC, Williams DA. Matrix molecule interactions with hematopoietic Stem cells[J].Exp Hematology,1995,23(9):961-976.
[66]Greenberger JS, Toxic effects on the hematopoietic micreenvironment [J].Exp Hematol,1991,19(4):1101-1109.
[67]Greenberger JS, Epperly MW, Jahroudi N, etal. Role of bone marrow stoma Cells in irradiation leukemogenesis. Acta Hematol [J],1996,96(1):1-15.
[68]Dainiak N. Hematologic consequences of exposure to ionizing radiation [J]. Exp Hematol,2002,30(6):513-528.
[69]Yang XB, Bhatnagar RS, Li S,etal. Biomimetic collagen scaffolds for Human bone cell growth and differentiation[J]. Tissue Eng,2004,10(7-8):1148-1159.
[72]李成章,任铁冠,樊明文.基质金属蛋白酶家族[J].口腔医学纵横杂志,1998,14(1)：50-53.
[73]Carlo Bastianutto, Asim Mian, Julie Symes, etal. Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow[J]. Cancer Res 2007,10112-10116.
[74]Anna Janowska-Wieczorek, Leah A, Marquez,etal. Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD341 Cells and Their Transmigration Through Reconstituted Basement Membrane[J]. Blood,93(10),1999,3379-3390.
[75]靳风艳,邱录贵,李桥川,等.基质金属蛋白酶9在粒细胞集落刺激因子诱导的造血干／祖细胞动员中的作用[J].2006,86(42)：2966-2970.
[76]Rafii S, Avecilla S, Shmelklv S, etal. Angiogenic factors reconstitute Hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann NY Acad Sci,2003,990:49.
[77]E. Camilla Forsberg, Susan S Prohaska, Sol Katzman, Differential Expression of Novel Potential Regulators in Hematopoietic Stem Cells. PLoS Genet.2005,1 (3):28.